Evans Andrew, Fung Victor S C, O'Sullivan John D, Stell Rick, White Richard, Williams David R, Femia Samira, Onuk Koray
Movement Disorders Program, Royal Melbourne Hospital, Australia.
Movement Disorders Unit, Department of Neurology, Westmead Hospital, Australia.
Clin Park Relat Disord. 2020 Oct 17;4:100075. doi: 10.1016/j.prdoa.2020.100075. eCollection 2021.
To evaluate the proportion of Parkinson's disease (PD) patients identified as having advanced Parkinson's disease (APD) according to physician's judgement in Australia.
This cross-sectional, non-interventional observational study was performed in movement disorder clinics from 18 countries. Results from Australia are presented. Participants included consecutive adults with PD attending routine clinical visits, or inpatients, who could speak English. The primary outcome was the proportion of patients diagnosed with APD via physician judgement.
100 patients were recruited in Australia: 61.0% (95% CI 51.4-70.6%) diagnosed with APD by physician judgement. Patients were 66.6 ± 8.5 years, 65% were male, were living at home (97%), and diagnosed with PD for median 10.7 years (0-30.5 years). Motor fluctuations were present in 68%. For those with APD, referral was predominantly to enable access to device assisted therapies (DAT) (49%), while for non-APD, referral was largely for diagnostic purposes (41%). Patients had a median follow-up at the movement disorder clinic of 4.8 years for those with APD, or 3.6 years for non-APD. While 62% were eligible for DAT, only two-thirds of these received them. The most commonly used DAT was deep brain stimulation (64.3%). There was fair agreement between physician's judgement and the APD criteria by Delphi method (Cohen's kappa) 0.325 (95% CI 0.150-0.500) in the Australian subset.
The definition of APD requires refinement in order to facilitate greater agreement among movement disorder specialists. A third of APD patients eligible for DAT remain untreated. Better referral and education of patients with APD is needed.
根据澳大利亚医生的判断,评估被认定为患有晚期帕金森病(APD)的帕金森病(PD)患者比例。
这项横断面、非干预性观察性研究在18个国家的运动障碍诊所进行。本文呈现澳大利亚的研究结果。参与者包括连续就诊的成年PD患者或住院患者,且这些患者会说英语。主要结局是通过医生判断被诊断为APD的患者比例。
在澳大利亚招募了100名患者:经医生判断,61.0%(95%可信区间51.4 - 70.6%)被诊断为APD。患者年龄为66.6 ± 8.5岁,65%为男性,97%居家生活,诊断为PD的中位时间为10.7年(0 - 30.5年)。68%的患者存在运动波动。对于APD患者,转诊主要是为了能够接受器械辅助治疗(DAT)(49%),而对于非APD患者,转诊主要是用于诊断目的(41%)。APD患者在运动障碍诊所的中位随访时间为4.8年,非APD患者为3.6年。虽然62%的患者符合接受DAT的条件,但其中只有三分之二接受了此类治疗。最常用的DAT是深部脑刺激(64.3%)。在澳大利亚的亚组中,医生的判断与德尔菲法确定的APD标准之间存在中等程度的一致性(科恩kappa系数)为0.325(95%可信区间0.150 - 0.500)。
APD的定义需要细化,以便促进运动障碍专家之间达成更大程度的共识。三分之一符合接受DAT条件的APD患者仍未得到治疗。需要对APD患者进行更好的转诊和教育。